FIA
SSKN

FNY Investment Advisers’s Strata Skin Sciences SSKN Stock Holding History

FNY Investment Advisers’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,121
Closed -$49K – 830
2022
Q2 		$49K Buy
+5,121
New +$60.8K 0.04% 232

Other funds holding SSKN

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return

FNY Investment Advisers's SSKN Position: Q3 2022 in Review

FNY Investment Advisers sold out of Strata Skin Sciences (SSKN) in Q3 2022, closing a stake of 5,121 shares — an estimated $49K sold.

FNY Investment Advisers first reported a position in SSKN in Q2 2022 and held it in 1 quarter. The position peaked at $49K in Q2 2022. 26 funds tracked by Wall St. Rank hold SSKN as of Q3 2022.

  • FNY Investment Advisers reported no remaining Strata Skin Sciences position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 5,121 Strata Skin Sciences shares in Q3 2022, an estimated $49K.
  • FNY Investment Advisers first reported a position in Strata Skin Sciences in Q2 2022 and held it in 1 quarter.
  • FNY Investment Advisers's Strata Skin Sciences position peaked at $49K in Q2 2022.
  • 26 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.